Quantitative Investment Management, LLC Tg Therapeutics, Inc. Transaction History

Quantitative Investment Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$13.32 - $19.19 $532,626 - $767,350	39,987 New	39,987 $711,000
Q2 2023 Aug 14, 2023	BUY	$15.48 - $35.0 $376,953 - $852,285	24,351 New	24,351 $604,000
Q2 2021 Aug 16, 2021	SELL	$32.5 - $48.96 $715,975 - $1.08 Million	-22,030 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$41.61 - $54.3 $1.71 Million - $2.24 Million	-41,206 Reduced 65.16%	22,030 $1.06 Million
Q4 2020 Feb 16, 2021	BUY	$25.27 - $54.9 $1.6 Million - $3.47 Million	63,236 New	63,236 $3.29 Million
Q3 2018 Nov 14, 2018	SELL	$5.15 - $14.0 $762,715 - $2.07 Million	-148,100 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$12.5 - $15.0 $406,250 - $487,500	32,500 Added 28.11%	148,100 $1.95 Million
Q1 2018 May 15, 2018	BUY	$8.7 - $16.8 $1.01 Million - $1.94 Million	115,600 New	115,600 $1.64 Million

338

88.3M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.29B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Investment Management, LLC with notifications on news.